SARS-CoV-2 infection in pediatric population

Main Article Content

Sara Manti
Amelia Licari
Lorenza Montagna
Martina Votto
Salvatore Leonardi
Ilaria Brambilla
Riccardo Castagnoli
Thomas Foiadelli
Gian Luigi Marseglia
Fabio Cardinale
Carlo Caffarelli
Maria Angela Tosca
Claudio Cravidi
Marzia Duse
Elena Chiappini


childchildren; SARS-CoV-2; COVID-19


n December 2019, in Wuhan (Hubei, China), the first COVID-19 cases due to SARS-COV-2 had been reported. On July 1st 2020, more than 10.268.839 million people had developed the disease, with at least 506.064 deaths. At present, Italy is the third country considering the number of cases (n=240.760), after Spain, and the second for the cumulative number of deaths (n=249.271), after the United States. As regard pediatric COVID-19 cases, more than 4000 cases (have been reported; however, these figures are likely to be underestimated since they are influenced by the number of diagnostic tests carried out. Three pediatric deaths have been reported in Italy to date. We aimed to review the peculiar aspects of SARS-COV-2 infection in the pediatric population.


Download data is not yet available.
Abstract 1216 | PDF Downloads 522


1. European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of 7 July 2020. Available at: . Last Access July 8, 2020.
2. Ministero della salute. Covid-19 Situazione in Italia. Available at: Last Access July 3rd, 2020.
3. L'epidemiologia per la sanità pubblica. Istituto Superiore di Sanità. Coronavirus. Available at: Last Access July 3rd, 2020
4. Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health 2020;
5. Brambilla I, Castagnoli R, Caimmi S, et al. COVID-19 in the Pediatric population admitted to a tertiary referral hospital in Northern Italy: preliminary clinical data. Pediatr Infect Dis J 2020;39:160.
6. Garazzino S, Montagnani C, Donà D, et al. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Eurosurveillance. 2020;25(18):pii=2000600.
7. Parri N, Lenge M, Buonsenso D. Children with Covid-19 in pediatric emergency departments in italy. N Engl J Med 2020;383:187-190.
8. Chiotos K, Hayes M, Kimberlin DW, et al. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc 2020;piaa045 piaa045. doi: 10.1093/jpids/piaa045. Online ahead of print.
9. Dayal D. We urgently need guidelines for managing COVID-19 in children with comorbidities. Acta Paediatr 2020;109:1497-1498.
10. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR). Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020. Available at: Last Access May 1st, 2020.
11. Pathak EB, Salemi JL, Sobers N, et al. COVID-19 in children in the United States: intensive care admissions, estimated total infected, and projected numbers of severe pediatric cases in 2020. J Public Health Manag Pract 2020;10:1097.
12. Castagnoli R, Votto M, Licari A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr 2020;10.1001/jamapediatrics.2020.1467 [published online ahead of print, 2020 Apr 22].
13. Wang Y, Wang Y, Chen Y, et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 2020;92:568-576.
14. Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020;S1473-3099(20): 30287-5 [published online ahead of print, 2020 Apr 27] .
15. Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ 2020;368:m1165.
16. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020;145:e20200702.
17. Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition). Zhonghua Er Ke Za Zhi 2020;58: 169–174.
18. Tagarro A, Epalza C, Santos M, et al. Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr 2020;e201346. [published online ahead of print, 2020 Apr 8].
19. Streng A, Hartmann K, Armann J, et al. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31.03.2020) und erste Daten aus Deutschland [COVID-19 in hospitalized children and adolescents. Monatsschr Kinderheilkd 2020;doi: 10.1007/s00112-020-00919-7 [Epub ahead of print].
20. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020;109:1088-1095.
21. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020;39:355-368.
22. Mallineni SK, Innes NP, Raggio DP, et al. Coronavirus disease (COVID-19): characteristics in children and considerations for dentists providing their care. Int J Paediatr Dent 2020;30:245-250.
23. García-Salido A, Leoz-Gordillo I, Martínez de Azagra-Garde A, et al. Children in critical care due to severe acute respiratory syndrome coronavirus 2 infection: experience in a Spanish Hospital. Pediatr Crit Care Med 2020;7:10.1097/PCC.0000000000002475. [published online ahead of print, 2020 May 27]
24. Sun P, Lu X, Xu C, et al. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92:548–551.
25. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020;10.1001/jamapediatrics.2020.1948. [published online ahead of print, 2020 May 11]
26. Zachariah P, Johnson CL, Halabi KC, et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. JAMA Pediatr 2020:e202430. [published online ahead of print, 2020 Jun 3].
27. Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med 2020;382: 1663-1665.
28. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 2020;26:502-505.
29. Paret M, Lighter J, Pellett Madan R, et al. SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory. Clin Infect Dis 2020; ciaa452. [published online ahead of print, 2020 Apr 17].
30. Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol 2020:138:575-578.
31. McCrindle BW, Manlhiot C. SARS-CoV-2–related inflammatory multisystem syndrome in children: different or shared etiology and pathophysiology as Kawasaki Disease? JAMA 2020;10.1001/jama.2020.10370. [published online ahead of print, 2020 Jun 8].
32. Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 JAMA 2020;e2010369. [published online ahead of print, 2020 Jun 8].
33. Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol 2020;309:70–77.
34. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020;34:e212-e213.
35. Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020;98;219-227.
36. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020;413:116832.
37. Vetter P, Eckerle I, Kaiser L. Covid-19: a puzzle with many missing pieces. BMJ 2020; 368:m627.
38. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020:e203786. [published online ahead of print, 2020 Mar 11].
39. Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID‐19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020; 10.1164/rccm.202003-0543
40. Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement. World J Pediatr 2020;16:223-231.
41. Ministero della Salute. Circolare del Ministero della Salute del 3 aprile 2020 sui test diagnostici. Available at: Last Access May 1st, 2020.
42. WHO. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Interim guidance, 22 March 2020. Available at: Last Access July 1st, 2020.
43. Cai J, Xu J, Lin D, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological factors. Clin Infect Dis 2020:ciaa198. [published online ahead of print, 2020 Feb 28].
44. Foust AM, Phillips GS, Chu WC, et al. International expert consensus statement on chest imaging in pediatric COVID-19 patient management: imaging findings, imaging study reporting and imaging study recommendations. radiology: cardiothoracic imaging 2020;2;
45. Denina M, Scolfaro C, Silvestro E et al. Lung ultrasound in children with COVID-19. Pediatrics 2020;146:e20201157.
46. Carlotti APCP, Carvalho WB, Johnston C, et al. COVID-19 diagnostic and management protocol for pediatric patients. Clinics (Sao Paulo) 2020;75:e1894.
47. Principi N, Esposito S. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Lancet Infect Dis 2020;S1473-3099(20):30296-6. [published online ahead of print, 2020 Apr 17].
48. Ford N, Vitoria M, Rangaraj A, et al.. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment. J Int AIDS Soc 2020;23:e25489.
49. Luo P, Liu Y, Qiu L, et al. Tocilizumab treatment in COVID-19: A single center experience. J Med Virol 2020;10.1002/jmv.25801.
50. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;105949.
51. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094‐1099.
52. Reiter RJ, Abreu-Gonzalez P, Marik PE, et al. Therapeutic algorithm for use of melatonin in patients with COVID-19. Front Med (Lausanne) 2020;7:226.
53. Gitto E, Marseglia L, D'Angelo G, et al. Melatonin versus midazolam premedication in children undergoing surgery: A pilot study. J Paediatr Child Health 2016;52:291-5.
54. Marseglia L, Manti S, D'Angelo G, et al. Potential use of melatonin in procedural anxiety and pain in children undergoing blood withdrawal. J Biol Regul Homeost Agents 2015;29: 509-14.
55. Brambilla I, Tosca MA, De Filippo M, et al. Special issues for COVID-19 in children and adolescents. Obesity 2020; DOI: 10.1002/oby.22878. [published online ahead of print, 2020 May 12].
56. Licari A, Votto M, Brambilla I, et al. Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares? Allergy 2020;10.1111/all.14369.
57. Cardinale F, Ciprandi G, Barberi S, et al. Consensus statement of the Italian Society of Pediatric Allergy and Immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr 2020;46:84.
58. Manti S, Parisi GF, Papale M, et al. Cystic fibrosis: fighting together against coronavirus infection. Front Med (Lausanne) 2020;7:307.
59. Ciprandi G, Licari A, Filippelli G, et al. Children and adolescents with allergy and/or asthma seem to be protected from COVID-19. Ann Allergy Asthma Immunol 2020 In Press.
60. National Institutes of Health. COVID treatment guidelines. Available at: Last Access July 3rd, 2020.
61. Buzzi C, Tucci M, Ciprandi R, et al. The psycho-social effects of COVID-19 on Italian adolescents’ attitudes and behaviors. Ital J Pediatr. 2020 In Press.
62. Iozzi L, Brambilla I, Foiadelli T, et al. Paediatric emergency department visits fell by more than 70% during the COVID-19 lockdown in Northern Italy. Acta Pediatr 2020 In Press.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 > >>